Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 32 of 41, showing 5 Applications out of 204 total, starting on record 156, ending on 160

# Protocol No Study Title Investigator(s) & Site(s)

156.

ECCT/17/06/01   MF/PM Phase III
    An Open Label, Phase III, Randomized Controlled, Multicentre Non-Inferiority Trial to Compare Efficacy and Safety of Miltefosine and Paromomycin with Sodium Stibogluconate and Paromomycin Combination for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa       
Principal Investigator(s)
1. Jane Mbui
Site(s) in Kenya
1. Kimalel Health Centre (Baringo county)
2. Kacheliba sub-county hospital (West Pokot county)
 
View

157.

ECCT/17/03/05   HOPE Sickle Cell Disease Clinical Study
    A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease   
Principal Investigator(s)
1. Videlis Nduba
2. Jessie Nyokabi Githanga
Site(s) in Kenya
1. Gertrude\'s Children\'s Hospital (Nairobi City county)
2. Strathmore University Medical Center (Nairobi City county)
3. KEMRI CRDR Clinical Research clinic at Chandaria Health Center (Nairobi City county)
4. KEMRI Kondele Childrens Hospital Center for Clinical Research (Kisumu county)
5. KEMRI Clinical Research Center at Siaya County Referral Hospital (Siaya county)
 
View

158.

ECCT/17/03/02   The Edoxaban Hokusai VTE PEDIATRICS Study
    A PHASE 3, OPEN-LABEL, RANDOMIZED, MULTICENTER, CONTROLLED TRIAL TO EVALUATE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN AND TO COMPARE THE EFFICACY AND SAFETY OF EDOXABAN WITH STANDARD OF CARE ANTICOAGULANT THERAPY IN PEDIATRIC SUBJECTS FROM BIRTH TO LESS THAN 18 YEARS OF AGE WITH CONFIRMED VENOUS THROMBOEMBOLISM (VTE)   
Principal Investigator(s)
1. Bernhards Ragama Ogutu Ragama
Site(s) in Kenya
1. Gertrudes Hospital (Nairobi City county)
2. Mater Hospital (Nairobi City county)
 
View

159.

ECCT/16/12/02   Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis:
    Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial.   
Principal Investigator(s)
1. ISAAC TSIKHUTSU
Site(s) in Kenya
KEMRI/WRP, KERICHO
 
View

160.

ECCT/16/11/03   COAST
    Childrens Oxygen Administration Strategies Trial   
Principal Investigator(s)
1. Kathryn Maitland
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast Provincial General Hospital (Mombasa county)
 
View